Material and methods for treating or preventing HER-3 associated diseases
US12139549B2 · kind B2 · utility
0Cited by
44References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 27, 2017 |
| Grant date | Nov 12, 2024 |
| Priority date | — |
| Expiry date | Apr 2, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are materials and methods for treating subjects having a HER-3 associated disease, by administering a first agent that binds to HER-3, in combination with a second agent that binds and/or inhibits another member of the HER family. The first and the second agent may be a biologic, such as an antigen-binding protein, or a small molecular tyrosine kinase inhibitor, for example.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.